Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:978-985

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, G.
Right arrow Articles by Egan, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, G.
Right arrow Articles by Egan, B. M.

(Hypertension. 1998;31:978-985.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Oleic Acid and Angiotensin II Induce a Synergistic Mitogenic Response in Vascular Smooth Muscle Cells

Gang Lu; Kathryn E. Meier; Ayad A. Jaffa; Steven A. Rosenzweig; ; Brent M. Egan

From the Departments of Pharmacology (G.L., K.E.M., A.A.J., S.A.R., B.M.E.) and Medicine (A.A.J., B.M.E.), Medical University of South Carolina (Charleston).

Correspondence to Brent M. Egan, MD, Division of Clinical Pharmacology, Medical University of South Carolina, 171 Ashley Ave, CSB 826H, Charleston, SC 29464.

Abstract—Oleic acid and angiotensin II (Ang II) are elevated and may interact to accelerate vascular disease in obese hypertensive patients. We studied the effects of oleic acid and Ang II on growth responses of rat aortic smooth muscle cells (VSMCs). Oleic acid (50 µmol/L) raised thymidine incorporation by 50% at 24 hours and cell number by 55% at 6 days (P<.05). Ang II (10-11 to 10-6 mol/L) did not significantly increase thymidine incorporation or VSMC number. Combining Ang II and 50 µmol/L oleic acid doubled thymidine incorporation and VSMC number. Losartan, an angiotensin type 1 (AT1) receptor antagonist, blocked the synergistic interaction between Ang II and oleic acid, whereas the AT2 receptor antagonist PD 123319 did not. Protein kinase C inhibition and downregulation, as well as inhibition of extracellular signal-regulated kinase (ERK) activation by PD 98059, eliminated the rise of thymidine incorporation in response to oleic acid and the synergistic interaction with Ang II. However, the response to 10% fetal bovine serum was unaffected. An antisense oligodeoxynucleotide to ERK-1 and ERK-2 reduced ERK protein expression and activation by 83% and 75%, respectively. Antisense prevented the rise of thymidine incorporation in response to oleic acid and the synergy with Ang II. Antisense reduced but did not prevent increased thymidine incorporation in response to serum. The data indicate that oleic acid and Ang II exert a synergistic mitogenic effect in VSMCs and suggest an important role for the AT1 receptor, PKC, and ERK in this synergy. The observations raise the possibility that a synergistic mitogenic interaction between oleic acid and Ang II accelerates vascular remodeling in obese hypertensive patients.


Key Words: muscle, smooth, vascular • oleic acid • angiotensin II • receptors, angiotensin • protein kinase C • extracellular signal-regulated kinases • oligonucleotides, antisense




This article has been cited by other articles:


Home page
Vasc MedHome page
R. H Boger, E. Schwedhelm, R. Maas, S. Quispe-Bravo, and C. Skamira
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study
Vascular Medicine, July 1, 2005; 10(1_suppl): S97 - S102.
[Abstract] [PDF]


Home page
Vasc MedHome page
R. H Boger, E. Schwedhelm, R. Maas, S. Quispe-Bravo, and C. Skamira
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study
Vascular Medicine, May 1, 2005; 10(2_suppl): S97 - S102.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
B. Askari, M. A. Carroll, M. Capparelli, F. Kramer, R. G. Gerrity, and K. E. Bornfeldt
Oleate and Linoleate Enhance the Growth-promoting Effects of Insulin-like Growth Factor-I through a Phospholipase D-dependent Pathway in Arterial Smooth Muscle Cells
J. Biol. Chem., September 20, 2002; 277(39): 36338 - 36344.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Haastrup, C. A. Gadegbeku, D. Zhang, Y. V. Mukhin, E. L. Greene, A. A. Jaffa, and B. M. Egan
Lipids Stimulate the Production of 6-keto-prostaglandin F1{alpha} in Human Dorsal Hand Veins
Hypertension, October 1, 2001; 38(4): 858 - 863.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. P. Stojiljkovic, D. Zhang, H. F. Lopes, C. G. Lee, T. L. Goodfriend, and B. M. Egan
Hemodynamic effects of lipids in humans
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1674 - R1679.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. L. Greene, G. Lu, D. Zhang, and B. M. Egan
Signaling Events Mediating the Additive Effects of Oleic Acid and Angiotensin II on Vascular Smooth Muscle Cell Migration
Hypertension, February 1, 2001; 37(2): 308 - 312.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X.-P. Xi, K. Graf, S. Goetze, E. Fleck, W. A. Hsueh, and R. E. Law
Central Role of the MAPK Pathway in Ang II–Mediated DNA Synthesis and Migration in Rat Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 73 - 82.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Lu, E. L. Greene, T. Nagai, and B. M. Egan
Reactive Oxygen Species Are Critical in the Oleic Acid–Mediated Mitogenic Signaling Pathway in Vascular Smooth Muscle Cells
Hypertension, December 1, 1998; 32(6): 1003 - 1010.
[Abstract] [Full Text] [PDF]